Schedule 13D ownership disclosure

Inhibitor Therapeutics, Inc.

Security class unavailable · CUSIP: 45720M105

Event date: 2023-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-151524
Form type
SC 13D
Filer
Black Robe Capital LLC
CIK
CIK 1977553
Filed
May 23, 2023
Reporting period
May 05, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub